Mimedx (MDXG) Enterprise Value Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.68% |
| Dec 31, 2025 | -36.06% |
| Sep 30, 2025 | -24.73% |
| Jun 30, 2025 | -17.92% |
| Mar 31, 2025 | -12.04% |
| Dec 31, 2024 | -6.24% |
| Sep 30, 2024 | 0.67% |
| Jun 30, 2024 | 6.70% |
| Mar 31, 2024 | 16.98% |
| Dec 31, 2023 | 5.06% |
| Jun 30, 2023 | -12.51% |
| Mar 31, 2023 | -4.60% |
| Dec 31, 2022 | 1.53% |
| Sep 30, 2022 | 8.03% |
| Jun 30, 2022 | 9.22% |
| Mar 31, 2022 | -38.67% |
| Dec 31, 2021 | -24.51% |
| Dec 31, 2020 | -51.64% |
| Sep 30, 2020 | -44.24% |
| Jun 30, 2020 | -0.47% |
| Mar 31, 2020 | -20.05% |
| Dec 31, 2019 | -31.58% |
| Sep 30, 2019 | -72.50% |
| Jun 30, 2019 | -59.67% |
| Mar 31, 2019 | -17.23% |
| Dec 31, 2018 | -15.48% |
| Dec 31, 2017 | 19.33% |
| Sep 30, 2017 | 8.23% |
| Jun 30, 2017 | -6.60% |
| Mar 31, 2017 | 10.42% |
| Dec 31, 2016 | 11.72% |
| Sep 30, 2016 | -44.63% |
| Jun 30, 2016 | -78.38% |
| Mar 31, 2016 | -45.45% |
| Dec 31, 2015 | -63.09% |
| Sep 30, 2015 | -84.12% |
| Jun 30, 2015 | -158.49% |
| Mar 31, 2015 | -145.49% |
| Dec 31, 2014 | -133.45% |
| Sep 30, 2014 | -320.13% |
| Jun 30, 2014 | -189.69% |
| Mar 31, 2014 | -248.03% |
| Dec 31, 2013 | -220.34% |